January 19th 2025
Artificial intelligence (AI) models, particularly artificial neural networks and machine learning, outperform traditional methods in predicting post–complete cytoreduction outcomes in patients with ovarian cancer, including overall survival, no residual disease, and postoperative complications.
Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.
Therapists’ Perspectives on Access to Telemental Health Among Medicaid-Enrolled Youth
This qualitative study elucidates therapists’ perspectives on barriers to and facilitators of access to telemental health among Medicaid-enrolled youth served by a large safety-net organization.
Read More
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
What We’re Reading: AI Heart Attack Detection; FDA Menthol Ban; Shooting Survivor Care Obstacles
November 7th 2023Artificial intelligence (AI) could help detect heart attack risk signs and prevent sudden cardiac death; Advocates demand the Biden administration finalize the proposed FDA ban on menthol cigarettes; Gun violence survivors and their families have many ongoing medical needs.
Read More
Dr Sara Horst Shares Current, Future Improvements to VUMC’s Digital Health Systems
November 4th 2023Sara Horst MD, MPH, FACG, discusses recent improvements she helped make to the Vanderbilt University Medical Center's (VUMC) digital health systems and what changes she plans to help implement in the future.
Watch
Despite Risk, Patients With SCD Hopeful About Gene Therapies
November 2nd 2023Sickle cell disease (SCD) has known complications that include organ damage and failure, rhabdomyolysis, glaucoma, splenic sequestration, and vaso-occlusive crises. At present, the only potential cure is a bone marrow transplant, but it can be difficult to find a donor and there is a high rejection risk.
Read More
Updates in Federal Legislation Addressing Digital Therapeutics, Access to Care
October 28th 2023Although all legislation is currently on hold in Congress, there are important actions under consideration for pharmacy, including digital therapeutics, access to care, and health care disparities.
Read More
Allina Health’s Mike Koroscik on Revolutionizing Early Cancer Detection Through Technology
October 26th 2023Through the integration of a population health reimbursement model in 2020, Allina Health Cancer Institute was able to implement expanded screening initiatives through the use of artificial intelligence and precision medicine, according to Mike Koroscik, MBA, MHA, vice president of oncology, Allina Health.
Watch
The Biden administration requested $1.55 billion from Congress to help address the nationwide fentanyl crisis; the US Department of Agriculture reported that millions more Americans were food insecure in 2022; the Biden administration released an updated cybersecurity toolkit to help defend the US health care infrastructure against hackers.
Read More
Overcoming the Efficacy-Effectiveness Gap in Cancer Therapy Research
October 21st 2023With stringent criteria, randomized controlled trials are the cornerstone of cancer intervention research, but the result is they do not represent the majority of patients, which leads to a gap between the efficacy seen in trials and the effectiveness in the real-world setting.
Read More
Opt-In vs Opt-Out Patient Outreach Programs Yield Similar Mammography Completion Rates
October 21st 2023No differences in mammography completion were observed between an automated opt-out vs an opt-in patient outreach program for breast cancer screening, according to a randomized controlled trial. However, differences in administration burden between programs could lead clinics to prefer one over the other.
Read More
Dr Brian Mullen Shares Digital Health Advancements at The Clinic by Cleveland Clinic
October 19th 2023Brian Mullen, PhD, head of innovation and product at The Clinic by Cleveland Clinic, discusses the implementation of digital health tools and strategies made by The Clinic and what these improvements mean for its patients.
Watch
As More Gene Therapies Come to Market, Access and Affordability Remain Concerns
October 19th 2023Operational forecasting for patients who are eligible for gene therapies will be crucial for addressing the accessibility and affordability challenges with these agents, especially as more gene therapies are expected to enter the market in the next few years.
Read More
Case Report of Patient Death Following High-Dose Gene Therapy for DMD
October 19th 2023In this case study, a patient who had Duchenne muscular dystrophy (DMD) and received high-dose transgene therapy to upregulate cortical dystrophin subsequently developed acute respiratory distress syndrome and died.
Read More
What We’re Reading: Alzheimer Blood Tests; Year-Long Adderall Shortage; Type 2 Diabetes Management
October 12th 2023Blood tests offer a less invasive and more accessible means of detecting Alzheimer disease; Democrats address a year-long Adderall shortage; A new study shows significantly improved clinical outcomes in Type 2 diabetes management with a digital behavioral therapy app.
Read More
Dr Steven Deitelzweig: Identifying Patients With Atrial Fibrillation Using a Detection Device
October 10th 2023Steven Deitelzweig, MD, system chairman of hospital medicine at Ochsner Clinical School, professor of medicine at the University of Queensland, discusses key findings from a recent study on the accuracy of atrial fibrillation detection devices.
Watch